IP Verse

Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers - EP3236985

The patent EP3236985 was granted to Immatics Biotechnologies on Sep 7, 2022. The application was originally filed on Dec 16, 2015 under application number EP15813809A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3236985

IMMATICS BIOTECHNOLOGIES
Application Number
EP15813809A
Filing Date
Dec 16, 2015
Status
Patent Maintained As Amended
Aug 5, 2022
Grant Date
Sep 7, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ADAPTIMMUNEJun 25, 2020MEWBURN ELLISADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTJP4406607B
INTERNATIONAL-SEARCH-REPORTUS2014273275
INTERNATIONAL-SEARCH-REPORTWO0144279
INTERNATIONAL-SEARCH-REPORTWO2004061423
INTERNATIONAL-SEARCH-REPORTWO2013070603
INTERNATIONAL-SEARCH-REPORTWO2014039675
INTERNATIONAL-SEARCH-REPORTWO2014118552
OPPOSITIONWO2008021290
OPPOSITIONWO2010034514

Non-Patent Literature (NPL) Citations (18) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Munehide Nakatsugawa, "Identification of an HLA-A 2010- restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, lengsin", International Journal of Oncology, (20110101), vol. 39, pages 1041 - 1049, XP055763964-
OPPOSITION- Steve Pascolo et al, "A MAGE-A1 HLA-A*0201 Epitope Identified by Mass Spectrometry 1", CANCER RESEARCH, (20010315), pages 4072 - 4077, CANCER RESEARCH, URL: https://cancerres.aacrjournals.org/content/canres/61/10/4072.full.pdf, XP055664711-
OPPOSITION- Zheng-Cai Jia et al, "Identification of Two Novel HLA-A ∗ 0201-Restricted CTL Epitopes Derived from MAGE-A4", CLINICAL & DEVELOPMENTAL IMMUNOLOGY, Hindawi Publishing Corp, US, US , (20100101), vol. 2010, doi:10.1155/2010/567594, ISSN 1740-2522, pages 1 - 7-
OPPOSITION- Martin F. Bachmann, Et Al, "T cell responses are governed by avidity and co-stimulatory thresholds", European Journal of Immunology, Wiley VCH, Weinheim, Weinheim, (19960901), vol. 26, no. 9, doi:10.1002/eji.1830260908, ISSN 0014-2980, pages 2017 - 2022, XP055763974
OPPOSITION- Jan Petersen ; Anthony W. Purcell ; Jamie Rossjohn, "Post-translationally modified T cell epitopes: immune recognition and immunotherapy", Journal of Molecular Medicine, Springer, Berlin, DE, Berlin, DE , (20090908), vol. 87, no. 11, doi:10.1007/s00109-009-0526-4, ISSN 1432-1440, pages 1045 - 1051, XP019750568
OPPOSITION- Govinda Sharma, Robert A. Holt, "T-cell epitope discovery technologies", HUMAN IMMUNOLOGY, NEW YORK, NY, US, US, (20140601), vol. 75, no. 6, doi:10.1016/j.humimm.2014.03.003, ISSN 0198-8859, pages 514 - 519, XP055763969
OPPOSITION- Nathaniel Liddy, Giovanna Bossi, Katherine J Adams, Anna Lissina, Tara M Mahon, Namir J Hassan, Jessie Gavarret, Frayne C Bianchi, Nicholas J Pumphrey, Kristin Ladell, Emma Gostick, Andrew K Sewell, Nikolai M Lissin, Naomi E Harwood, Peter E Molloy, Yi Li, Brian J Cameron, Malkit Sami, Emma E Baston, Penio T Todorov, Samantha J Paston, Rebecca E Dennis, Jane V Harper, Steve M Dunn, Rebecca Ashfield, Andy Johnson, Yvonne Mcgrath, Gabriela Plesa, Carl H June, Michael Kalos, David A Price, Annelise Vuidepot, Daniel D Williams, Deborah H Sutton, Bent K Jakobsen, "Monoclonal TCR-redirected tumor cell killing", Nature Medicine, Nature Publishing Group US, New York, New York, vol. 18, no. 6, doi:10.1038/nm.2764, ISSN 1078-8956, pages 980 - 987, XP055241791
OPPOSITION- Andreas O. Weinzierl, Et Al, "Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface", Molecular & Cellular Proteomics, American Society for Biochemistry and Molecular Biology, US, US, (20060814), vol. 6, no. 1, doi:10.1074/mcp.M600310-MCP200, ISSN 1535-9476, pages 102 - 113, XP055763954
OPPOSITION- Ellen C. Border, Joseph P. Sanderson, Thomas Weissensteiner, Andrew B. Gerry, Nicholas J. Pumphrey, "Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate", OncoImmunology, (20190201), vol. 8, no. 2, doi:10.1080/2162402X.2018.1532759, page e1532759, XP055637100
OPPOSITION- Thilo Muth, Bernhard Y Renard, "Evaluating de novo sequencing in proteomics: already an accurate alternative to database-driven peptide identification?", BRIEFINGS IN BIOINFORMATICS., OXFORD UNIVERSITY PRESS, OXFORD., GB, GB, (20180928), vol. 19, no. 5, doi:10.1093/bib/bbx033, ISSN 1467-5463, pages 954 - 970, XP055763951
OPPOSITION- M. P. Tan; A. B. Gerry; J. E. Brewer; L. Melchiori; J. S. Bridgeman; A. D. Bennett; N. J. Pumphrey; B. K. Jakobsen; D. A. Price; K. Ladell; A. K. Sewell, "T cell receptor binding affinity governs the functional profile of cancer‐specific CD8+ T cells", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, Wiley-Blackwell Publishing Ltd., GB, GB , (20150414), vol. 180, no. 2, doi:10.1111/cei.12570, ISSN 0009-9104, pages 255 - 270, XP071091083
OPPOSITION- COX A. L., ET AL., "IDENTIFICATION OF A PEPTIDE RECOGNIZED BY FIVE MELANOMA-SPECIFIC HUMAN CYTOTOXIC T CELL LINES.", Science, American Association for the Advancement of Science, US, US, (19940429), vol. 264., no. 5159., doi:10.1126/science.7513441, ISSN 0036-8075, pages 716 - 719., XP000882826
OPPOSITION- Zheng-Cai Jia, Bing Ni, Ze-Min Huang, Yi Tian, Jun Tang, Jing-Xue Wang, Xiao-Lan Fu, Yu-Zhang Wu, "Identification of Two Novel HLA-A ∗ 0201-Restricted CTL Epitopes Derived from MAGE-A4", CLINICAL & DEVELOPMENTAL IMMUNOLOGY, Hindawi Publishing Corp, US, US , (20100101), vol. 2010, doi:10.1155/2010/567594, ISSN 1740-2522, pages 1 - 7, XP055364879
OPPOSITION- Jelena Popović, Et Al, "Abstract", Blood, (20110728), vol. 118, no. 4, doi:10.1182/blood-2010-12-325035, ISSN 0006-4971, pages 946 - 954, XP055763958
OPPOSITION- Linette Gerald P., Stadtmauer Edward A., Maus Marcela V., Rapoport Aaron P., Levine Bruce L., Emery Lyndsey, Litzky Leslie, Bagg Adam, Carreno Beatriz M., Cimino Patrick J., Binder-Scholl Gwendolyn K., Smethurst Dominic P., Gerry Andrew B., Pumphrey Nick J., Bennett Alan D., Brewer Joanna E., Dukes Joseph, Harper Jane, Tayton-Martin Helen K., Jakobsen Bent K., Hassan Namir J., Kalos Michael, June Carl H., "Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma", Blood, American Society of Hematology, US, US , (20130808), vol. 122, no. 6, doi:10.1182/blood-2013-03-490565, ISSN 0006-4971, pages 863 - 871, XP055856597
OPPOSITION- Manfredi Francesco, Cianciotti Beatrice Claudia, Potenza Alessia, Tassi Elena, Noviello Maddalena, Biondi Andrea, Ciceri Fabio, Bonini Chiara, Ruggiero Eliana, "TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals", Frontiers in Immunology, vol. 11, doi:10.3389/fimmu.2020.01689, page 1689, XP055856596
OPPOSITION- Thomas Trolle et al, "The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference", The Journal of Immunology, Williams & Wilkins Co., (20160215), vol. 196, no. 4, doi:10.4049/jimmunol.1501721, ISSN 0022-1767, pages 1480 - 1487, XP055383890
OPPOSITION- Gfeller David, Guillaume Philippe, Michaux Justine, Pak Hui-Song, Daniel Roy T., Racle Julien, Coukos George, Bassani-Sternberg Michal, "The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands", The Journal of Immunology, Williams & Wilkins Co., US, US , (20181215), vol. 201, no. 12, doi:10.4049/jimmunol.1800914, ISSN 0022-1767, pages 3705 - 3716, XP055856593

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents